National Comprehensive Cancer Network



About NCCN

Occult Primary Panel - Disclosures as of 5/22/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Mark Agulnik, MD

None

None

None

None

4/6/2012

Mary Anne Bergman

None

None

None

None

9/11/2012

Justin M. Cates, MD, PhD

None

None

None

None

3/7/2013

Mihaela Cristea, MD

None

None

None

None

4/5/2012

Efrat Dotan, MD

Biocompatibles

None

None

None

5/17/2012

Keith D. Eaton, MD, PhD

Genentech, Inc.;
OSI Pharmaceuticals, Inc.;
Nova Rx;
Pfizer Inc.

None

None

None

5/23/2012

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix;
Gilead;
Roche Laboratories, Inc.

None

None

2/28/2013

Panagiotis M. Fidias, MD

None

None

None

None

4/4/2012

Deborah Freedman-Cass, PhD

None

None

None

None

3/7/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

David Gierada, MD

None

None

None

None

3/10/2013

Kelly Godby, MD

None

None

None

None

7/12/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Charles R. Handorf, MD, PhD

Pathwork Diagnostics

None

None

None

4/4/2012

Renuka Iyer, MD

None

pathworks diagnostics

None

None

8/8/2012

Renato Lenzi, MD

None

None

None

None

5/23/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

John Phay, MD

None

None

None

None

4/6/2012

Asif Rashid, MD

None

None

None

None

8/16/2012

Leonard Saltz, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
OSI Pharmaceuticals, Inc.;
Astellis;
Biothera;
Immunomedex;
Pfizer Inc.;
Roche Laboratories, Inc.;
Synta Pharmaceuticals Corp.;
Taiho Parmaceuticals Co., Ltd.

Bayer HealthCare;
CureTech Ltd.;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Taiho Parmaceuticals Co., Ltd.

None

None

8/27/2012

Lawrence N. Shulman, MD

None

None

None

None

3/7/2013

Jeffrey B. Smerage, MD, PhD

None

Amgen Inc.

None

None

4/11/2013

Marvaretta M Stevenson, MD

Pfizer Inc.

None

None

None

2/10/2013

Gauri R. Varadhachary, MD

Pathwork Diagnostics

bioTheranostics;
Pathwork

None

None

8/17/2012

Jonathan S. Zager, MD

None

Delcath Systems, Inc;
Delcath Systems, Inc.

None

None

3/8/2013

Weining (Ken) Zhen, MD

None

None

None

None

4/16/2013

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved